Bristol-Myers Squibb (BMY) Settles Clean-Air Case -Bloomberg
Bloomberg is reporting that Bristol-Myers Squibb (NYSE: BMY) has settle its clean-air case and will spend $3.7 million to reduce the amount of ozone at its plants. Similarly, Bristol-Myers will pay $127,000 in civil penalties.
Bristol-Myers Squibb Company (BMS) engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of pharmaceuticals and other health care related products worldwide.
Create E-mail AlertRelated Categories
Corporate NewsStocks Mentioned
-0.09Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
